A case of rapidly progressive IgA nephropathy in a patient with exacerbation of Crohns disease

BMC Nephrology

Volumn 13, Issue 1, 2012, Pages

  Choi, Ji Young ^a   Yu, Chung Hoon ^a   Jung, Hee Yeon ^a   Jung, Min Kyu ^a   Kim, Yong Jin ^b   Cho, Jang Hee ^a   Kim, Chan Duck ^a   Kim, Yong Lim ^a   Park, Sun Hee ^a  

^a Kyungpook National University School of Medicine   (South Korea)

^b Yeungnam University College of Medicine   (South Korea)

Author keywords

Crohns disease; Rapidly progressive IgA nephropathy

Indexed keywords

BUDESONIDE; CIPROFLOXACIN; CYCLOPHOSPHAMIDE; DEFLAZACORT; GLUCOCORTICOID; LOPERAMIDE; MESALAZINE; METRONIDAZOLE; MYCOPHENOLIC ACID; PREDNISOLONE;

ABDOMINAL PAIN; ADULT; ARTICLE; CASE REPORT; COLON ULCER; COLONOSCOPY; CROHN DISEASE; DIARRHEA; DISEASE COURSE; DISEASE EXACERBATION; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GASTROINTESTINAL SYMPTOM; HEMATURIA; HEMICOLECTOMY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; KIDNEY FUNCTION; MALE; PROTEINURIA; SURGICAL INFECTION; URINALYSIS;

ADOLESCENT; CROHN DISEASE; GLOMERULONEPHRITIS, IGA; HUMANS; MALE; STEROIDS; TREATMENT OUTCOME;

EID: 84864496326     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-13-84     Document Type: Article

References (23)

1. Urogenital complications of Crohn's disease. Kane S, Am J Gastroenterol 2006 101 12 Suppl 640 S643 17177869
2. Renal and urologic complications of inflammatory bowel disease. Pardi DS, Tremaine WJ, Sandborn WJ, McCarthy JT, Am J Gastroenterol 1998 93 4 504 514 10.1111/j.1572-0241.1998.156-b.x 9576439
3. Acute renal failure in Crohn's disease due to IgA nephropathy. Hirsch DJ, Jindal KK, Trillo A, Cohen AD, Am J Kidney Dis 1992 20 2 189 190 1496975
4. IgA nephropathy in association with Crohn's disease. Forshaw MJ, Guirguis O, Hennigan TW, Int J Colorectal Dis 2005 20 5 463 465 10.1007/s00384-004-0696- z 15668785
5. IgA nephropathy in association with Crohn's disease: a case report and brief review of the literature. Filiopoulos V, Trompouki S, Hadjiyannakos D, Paraskevakou H, Kamperoglou D, Vlassopoulos D, Ren Fail 2010 32 4 523 527 10.3109/08860221003710554 20446796
6. Crohn's disease in association with IgA nephropathy. Lee JM, Lee KM, Kim HW, Chung WC, Paik CN, Lee JR, Choi YJ, Yang JM, Korean J Gastroenterol 2008 52 2 115 119 19077504
7. Crohn's disease associated with IgA nephropathy. Youm JY, Lee OY, Park MH, Yang SY, Han SH, Baek YH, Park SR, Lee HL, Yoon BC, Choi HS, et al. Korean J Gastroenterol 2006 47 4 324 328 16632987
8. Rapidly progressive crescentic glomerulonephritis. Jennette JC, Kidney Int 2003 63 3 1164 1177 10.1046/j.1523-1755.2003.00843.x 12631105
9. Treatment of IgA nephropathy. Barratt J, Feehally J, Kidney Int 2006 69 11 1934 1938 10.1038/sj.ki.5000419 16641928
10. IL-17 is produced by some proinflammatory Th1/Th0 cells but not by Th2 cells. Aarvak T, Chabaud M, Miossec P, Natvig JB, J Immunol 1999 162 3 1246 1251 9973376
11. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. Jovanovic DV, Di Battista JA, Martel-Pelletier J, Jolicoeur FC, He Y, Zhang M, Mineau F, Pelletier JP, J Immunol 1998 160 7 3513 3521 9531313
12. Late Crohn's disease patients present an increase in peripheral Th17 cells and cytokine production compared with early patients. Veny M, Esteller M, Ricart E, Pique JM, Panes J, Salas A, Aliment Pharmacol Ther 2010 31 5 561 572 10.1111/j.1365-2036.2009.04209.x 19958311
13. Imbalance of regulatory T cells to Th17 cells in IgA nephropathy. Lin FJ JG, Shan JP, Zhu C, Zou J, Wu XR, Scand J Clin Lab Invest 2012 10.3109/00365513.2011.652158
14. Intestinal permeability and the prediction of relapse in Crohn's disease. Wyatt J, Vogelsang H, Hubl W, Waldhoer T, Lochs H, Lancet 1993 341 8858 1437 1439 10.1016/0140-6736(93)90882-H 8099141
15. Do intestinal hyperpermeability and the related food antigens play a role in the progression of IgA nephropathy? I. Study of intestinal permeability. Kovacs T, Kun L, Schmelczer M, Wagner L, Davin JC, Nagy J, Am J Nephrol 1996 16 6 500 505 10.1159/000169050 8955761
16. Persistent clonal expansions of peripheral blood CD4+ lymphocytes in chronic inflammatory bowel disease. Probert CS, Chott A, Turner JR, Saubermann LJ, Stevens AC, Bodinaku K, Elson CO, Balk SP, Blumberg RS, J Immunol 1996 157 7 3183 3191 8816432
17. Increase of IgA specific helper T alpha cells in patients with IgA nephropathy. Sakai H, Endoh M, Tomino Y, Nomoto Y, Clin Exp Immunol 1982 50 1 77 82 6217004
18. Distinct associations of HLA class II genes with inflammatory bowel disease. Toyoda H, Wang SJ, Yang HY, Redford A, Magalong D, Tyan D, McElree CK, Pressman SR, Shanahan F, Targan SR, et al. Gastroenterology 1993 104 3 741 748 8440433
19. HLA associations in IgA nephropathy and focal and segmental glomerulosclerosis. Freedman BI, Spray BJ, Heise ER, Am J Kidney Dis 1994 23 3 352 357 8128935
20. Circulating immune complexes containing IgA, IgG and IgM in patients with primary IgA nephropathy and with Henoch-Schoenlein nephritis. Correlation with clinical and histologic signs of activity. Coppo R, Basolo B, Martina G, Rollino C, De Marchi M, Giacchino F, Mazzucco G, Messina M, Piccoli G, Clin Nephrol 1982 18 5 230 239 7151337
21. An adolescent with IgA nephropathy and Crohn disease: pathogenetic implications. Takemura T, Okada M, Yagi K, Kuwajima H, Yanagida H, Pediatr Nephrol 2002 17 10 863 866 10.1007/s00467-002-0943-x 12376818
22. Clinical presentation, natural history, and treatment of crescentic proliferative IgA nephropathy. Tumlin JA, Hennigar RA, Semin Nephrol 2004 24 3 256 268 10.1016/j.semnephrol.2004.01.006 15156530
23. Glomerular nephropathy with IgA mesangium deposits and Crohn disease. Dabadie A, Gie S, Taque S, Babut JM, Roussey M, Arch Pediatr 1996 3 9 884 887 10.1016/0929-693X(96)87579-8 8949351